EXAS Congressional Stock Trades
Exact Sciences Corporation (EXAS)
Last disclosed trade Mar 24
Every disclosed trade in EXAS by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Kevin Hern · Sold $EXAS · Dec 19 · $50K–$100K
Managed-account penalty applied (x 0.20): filings dominated by trust or wealth-manager activity are discounted.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $EXAS
Get notified when any member of Congress trades $EXAS. Free, no card, no spam.
The record on $EXAS
Coldpine has parsed 8 disclosed trades in $EXAS by 2 members of Congress, drawn from 8 periodic transaction reports dated Dec 19, 2022 through Mar 24, 2026. All of them came from House members, filed 4 by Democrats and 4 by Republicans.
Of the 8 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 27 days. The longest was 40 days: a $EXAS sale by Kevin Hern dated Jan 2, 2024, disclosed Feb 11, 2024. How late filing is measured across all of Congress is in the late-filers study.
8 of the 8 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Josh Gottheimer filed the most $EXAS sales (4).
Activity peaked in 2024 with 3 trades.
Members who trade EXAS
Recent disclosed trades in EXAS
| Date | Member | Type | Amount |
|---|---|---|---|
| Mar 24 | Kevin Hern(OK) | sell | $1K–$15K |
| May 10 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Feb 1 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Jan 2 | Kevin Hern(OK) | sell | $1K–$15K |
| Nov 13 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Sep 15 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Jan 31 | Kevin Hern(OK) | sell | $1K–$15K |
| Dec 19 | Kevin Hern(OK) | sell | $50K–$100K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →